From: Lipid profile and risk of ovarian tumours: a meta-analysis
Authors | Year | Country | Cases | Control | Lipid profilea | Ascertainment of ovarian tumour cases | Classificationf | Accountability of bias |
---|---|---|---|---|---|---|---|---|
Bukhari et al. [7] | 2016 | Pakistan | 30 | 30e | TC, TG, HDL, LDLb | Hospital/Medical record confirmed using color flow Doppler tests, biopsies and MRI | NR | NR |
Camuzcuoglu et al. [6] | 2009 | Turkey | 24 | 29e | TC, TG, HDL, LDLb | Hospital/Medical record | FIGO | Excludedg, h |
Chen et al. [16] | 2017 | China | 573 | 1146d | TG, HDLb | Hospital confirmed | FIGO | Excludedh,i |
Das et al. [17] | 1987 | China | 28 | 66e | TCb | Histopathological examinations | NR | NR |
Delimaris et al. [10] | 2007 | Greece | 15 | 30d | TC, HDL, LDLb | Hospital/Medical records, | TNM | Excludedg |
Gadomska et al. [18] | 1997 | NR | 25 | 25e | TC, TG, HDLb | Histopathological examinations | FIGO | NR |
Gadomska et al. [9] | 2005 | Poland | 91 | 44 e | TC, TG, HDLb | Histopathological examinations, Transvaginal ultrasonography, | FIGO | NR |
Knapp et al. [19] | 2017 | Poland | 74 | 81e | TC, TG | Transvaginal sonography evaluation, Histopathological examinations, CT scan | FIGO | Excludedh,i |
1992 | Canada | 62 | 51e | TC, TG | NR | FIGO | NR | |
Melvin et al [8] | 2012 | Sweden | 786 | 227,603d | TC, TG, HDL, LDLb | Verifiable database | NR | NR |
Qadir et al. [21] | 2008 | Pakistan | 40 | 50d | TC, TG, HDL, LDLb | NR | NR | Excludedh |
Yam et al. [22] | 1994 | Israel | 19 | 12c | TC, TG, HDL, LDLb | Biopsies of ovary/endometrium | NR | NR |